VRTX Market Cap History
Below is a table of the VRTX market cap history going back to 2/16/2010:

Date VRTX Market Cap
2/16/20107.76B
4/22/20107.70B
7/29/20106.61B
10/21/20107.28B
2/9/20117.79B
4/28/201111.44B
7/29/201110.79B
10/28/20118.67B
2/8/20127.74B
4/27/20128.15B
7/27/201210.64B
10/26/201210.75B
2/15/20139.95B
4/26/201317.50B
7/26/201318.79B
10/31/201316.68B
2/5/201418.25B
4/25/201415.16B
7/25/201422.80B
10/31/201427.09B
1/15/201528.51B
4/24/201532.47B
7/24/201530.70B
10/23/201528.10B
1/31/201622.36B
4/20/201620.80B
7/22/201623.26B
10/21/201620.03B
2/10/201721.90B
4/21/201729.07B
7/21/201741.14B
10/20/201739.11B
1/31/201842.37B
4/20/201840.30B
7/20/201845.34B
10/19/201844.90B
1/31/201948.81B
4/24/201944.20B
7/26/201942.88B
7/25/20192.91B
10/18/201945.32B
1/31/202058.87B
4/24/202069.97B
7/23/202074.09B
10/23/202055.02B
1/31/202159.55B
4/22/202155.91B
7/23/202152.02B

Also see: VRTX Shares Outstanding History
and VRTX YTD Return
VRTX Historical Market Cap:
+18.10% CAGR
VRTX Historical Market Cap: +18.10% CAGR

Mouse over chart for data details
2/16/2010 ...7/23/2021
Vertex Pharmaceuticals develops and commercializes therapies for the treatment of cystic fibrosis (CF) and developing research and development programs in other indications. Co.'s marketed products are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor), which are approved to treat people with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene. Co. is co-developing CTX001, an investigational CRISPR/Cas9-based gene-editing therapy for sickle cell disease and transfusion-dependent beta thalassemia. We show 48 historical shares outstanding datapoints in our VRTX shares outstanding history coverage, used to compute VRTX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VRTX market cap history over the course of time is important for investors interested in comparing VRTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VRTX versus a peer is one thing; comparing VRTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VRTX can fluctuate over the course of history. With this page we aim to empower investors researching VRTX by allowing them to research the VRTX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

VRX Market Cap History
VSAR Market Cap History
VSTM Market Cap History
VTGN Market Cap History
VTL Market Cap History
VTRS Market Cap History
VTVT Market Cap History
VVOS Market Cap History
VVUS Market Cap History
VXRT Market Cap History
More Healthcare companies »

 

VRTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.